clinical trial · NCT06938204
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study
Innovo Therapeutics, Inc.·phase1·completed·n = 48
Healthy VolunteerINV-101INV-101 Placebo
brief summary
This is a 2-part study. Parts 1 and 2 will be a randomized, double-blind, placebo-controlled investigations of SAD (Part 1) and MAD (Part 2) of orally administered INV-101 in healthy adult subjects. Food effect will also be assessed in one cohort in Part 1.
started
Apr 1, 2024
primary completion
Aug 9, 2024
completion
Sep 13, 2024
last updated
Apr 22, 2025
official title
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of INV-101 Administered Orally to Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol